Skip to main content
Caplight Logo









PlaqueTec

PlaqueTec

Private
CambridgeHealthcare & Life Scienceshttps://www.plaquetec.com/

Last Round

Early Funding

Apr 26, 2026

Total Funding Raised

$13M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

PlaqueTec is a medtech company that develops a proprietary intracoronary liquid biopsy system and data analysis platform to identify biomarkers for coronary artery disease.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical Devices, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Data as a Service, Services & Consulting

AI Layer

Application

Keywords

liquid biopsyintracoronary samplingcardiovascular diseasemedtechproteomicspatient stratificationprecision medicinebiomarker discoverydrug discoverydata laketranslational medicinebioinformaticsclinical trial supportdata as a serviceDaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

PlaqueTec Comparables

Compare PlaqueTec with similar companies based on industry and business-model similarity.

PlaqueTec comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Thermo Fisher Scientific Inc.
69%
Multiomic Health
64%
Prevencio, Inc.
58%

PlaqueTec Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingApr 26, 2026
Early FundingApr 30, 2024

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 26, 2026

    Raised $5M in early funding.

  • Apr 30, 2024

    $8M raised, led by Future Fund UK Government and Baron Moynihan.

Recent news

Latest coverage and updates

  • hiresSep 7, 2026

    PlaqueTec Ltd. hired Diane as Chief Scientific Officer on Jul 1st '18.

PlaqueTec Filings

Explore SEC and related filing metadata, where available.

PlaqueTec filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about PlaqueTec's valuation, stock price, and market status.

Is PlaqueTec a public or private company?

PlaqueTec is a private company.

What is the current stock price of PlaqueTec?

PlaqueTec is a private company with no public stock price. No recent secondary market data is available.

How much is PlaqueTec worth (valuation)?

Valuation information for PlaqueTec is not publicly available.

Can I buy PlaqueTec stock?

PlaqueTec shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was PlaqueTec's last funding round?

PlaqueTec's most recent funding round was Early Funding on April 26, 2026.

Who are the main investors in PlaqueTec?

Investor information for PlaqueTec is not publicly disclosed.

Will PlaqueTec IPO soon?

No public IPO plans have been announced for PlaqueTec.

How can I track PlaqueTec secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor PlaqueTec's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCambridge
Employee Range5
Year Founded2007
Last FundingApr 26, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?